Neogen Corporation (NASDAQ:NEOG) — Market Cap & Net Worth
Market Cap & Net Worth: Neogen Corporation (NEOG)
Neogen Corporation (NASDAQ:NEOG) has a market capitalization of $2.60 Billion ($2.60 Billion) as of September 17, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #5346 globally and #1773 in its home market, demonstrating a 5.60% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Neogen Corporation's stock price $12.55 by its total outstanding shares 218106005 (218.11 Million). Also see Neogen Corporation (NEOG) total assets for a full breakdown of the balance sheet.
Neogen Corporation Market Cap History: 2015 to 2026
Neogen Corporation's market capitalization history from 2015 to 2026. Data shows change from $4.62 Billion to $2.74 Billion (-3.36% CAGR). Also see cash efficiency ratio of Neogen Corporation for how efficiently the company converts equity into cash flow.
Index Memberships
Neogen Corporation is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.66 Trillion | 0.10% | #143 of 976 |
|
NASDAQ Composite
IXIC
|
$41.69 Trillion | 0.01% | #605 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.61 Trillion | 0.10% | #247 of 602 |
Weight: Neogen Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Neogen Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Neogen Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check latest Neogen Corporation stock price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
3.14x
Neogen Corporation's market cap is 3.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $6.72 Billion | $361.59 Million | $43.79 Million | 18.59x | 153.54x |
| 2018 | $6.22 Billion | $402.25 Million | $63.15 Million | 15.45x | 98.44x |
| 2019 | $7.12 Billion | $414.19 Million | $60.18 Million | 17.18x | 118.27x |
| 2020 | $8.65 Billion | $418.17 Million | $59.48 Million | 20.68x | 145.40x |
| 2021 | $9.90 Billion | $468.46 Million | $60.88 Million | 21.14x | 162.68x |
| 2022 | $3.32 Billion | $527.16 Million | $48.31 Million | 6.30x | 68.76x |
| 2023 | $4.39 Billion | $822.45 Million | -$22.87 Million | 5.33x | N/A |
| 2024 | $2.65 Billion | $924.22 Million | -$9.42 Million | 2.86x | N/A |
| 2025 | $1.52 Billion | $894.66 Million | -$1.09 Billion | 1.70x | N/A |
| 2026 | $2.74 Billion | $870.40 Million | -$7.90 Million | 3.14x | N/A |
Competitor Companies of NEOG by Market Capitalization
Companies near Neogen Corporation in the global market cap rankings as of September 17, 2026. Review NEOG goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Neogen Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #229 globally with a market cap of $109.23 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.99 Billion | $102.36 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.60 |
| #229 | Stryker Corporation | NYSE:SYK | $109.23 Billion | $284.76 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Neogen Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Neogen Corporation's market cap moved from $4.62 Billion to $ 2.74 Billion, with a yearly change of -3.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.74 Billion | +79.54% |
| 2025 | $1.52 Billion | -42.42% |
| 2024 | $2.65 Billion | -39.63% |
| 2023 | $4.39 Billion | +32.04% |
| 2022 | $3.32 Billion | -66.46% |
| 2021 | $9.90 Billion | +14.53% |
| 2020 | $8.65 Billion | +21.51% |
| 2019 | $7.12 Billion | +14.49% |
| 2018 | $6.22 Billion | -7.55% |
| 2017 | $6.72 Billion | +24.56% |
| 2016 | $5.40 Billion | +16.77% |
| 2015 | $4.62 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Neogen Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.60 Billion USD |
| MoneyControl | $2.60 Billion USD |
| MarketWatch | $2.60 Billion USD |
| marketcap.company | $2.60 Billion USD |
| Reuters | $2.60 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Neogen Corporation
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage … Read more